Fusion Antibodies plc
Company Profile
Fusion is a Belfast based contract research organisation ("CRO") providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.
Latest Company Summary
Investor Access
Fusion will host an online live presentation open to all investors on Tuesday, 15 September at 11.30am BST, delivered by Dr Adrian Kinkaid, CEO and Stephen Smyth, interim CFO. The Company is committed to providing an opportunity for all existing and potential investors to hear directly from management on its results.
Investors can sign up to Investor Meet Company for free and add to meet Fusion Antibodies plc via the following link: https://www.investormeetcompany.com/fusion-antibodies-plc/register-investor.
Tuesday, 15 September at 11.30am BST
| Event | Date |
| Year End | 31 March |
| Half Year End | 30 September |
| Preliminary Results* | August |
| Interim Results | 24 November |
| AGM* | June |
* Months based on previous announcements of this kind
